CMX-2043

• CAT Number: I006182
• CAS Number: 910627-26-8
• Molecular Formula: C16H26N2O6S2
• Molecular Weight: 406.51
• Purity: ≥95%
• Synonyms: CMX-2043; CMX2043; CMX2043; LIP-EA; R-LIP-EA-OH; LIPEA; RLIPEAOH; LIP EA; R LIP EA OH;(S)-4-(5-((R)-1,2-dithiolan-3-yl)pentanamido)-5-(((S)-1-carboxyethyl)amino)-5-oxopentanoic acid
• Target: Metabolic Enzyme/Protease
• Solubility: Soluble in DMSO
• Storage: 0 - 4°C for short term ,or -20 °C for long term
• IUPAC Name: (4S)-5-[[(1S)-1-carboxyethyl]amino]-4-[5-[(3R)-dithiolan-3-yl]pentanoylamino]-5-oxopentanoic acid
• InChI: InChI=1S/C16H26N2O6S2/c1-10(16(23)24)17-15(22)12(6-7-14(20)21)18-13(19)5-3-2-4-11-8-9-25-26-11/h10-12H,2-9H2,1H3,(H,17,22)(H,18,19)(H,20,21)(H,23,24)/t10-,11+,12-/m0/s1
• InChIKey: MQXRTCVZPIHBLD-TUAOUCFPSA-N
• SMILES: CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CCCCC1CCSS1

CMX-2043(CAT: I006182) is a novel cardioprotective compound being investigated for its potential to reduce ischemia-reperfusion injury in heart disease and related conditions. This compound is believed to act through multiple pathways, including antioxidant, anti-apoptotic, and anti-inflammatory mechanisms, helping to protect heart tissue during and after events like heart attacks or surgery. CMX-2043 has shown promise in preclinical and clinical studies as a treatment to mitigate the damage caused by oxidative stress and inflammation. Its unique properties make it a valuable tool in cardiovascular research, with potential therapeutic applications in myocardial infarction and cardiac surgery recovery.